34 related articles for article (PubMed ID: 15865605)
1. CKB affects human osteosarcoma progression by regulating the p53 pathway.
Zhou F; Dou X; Li C
Am J Cancer Res; 2022; 12(10):4652-4665. PubMed ID: 36381321
[TBL] [Abstract][Full Text] [Related]
2. Matrilysins and Stromelysins in Pathogenesis and Diagnostics of Cancers.
Piskór BM; Przylipiak A; Dąbrowska E; Niczyporuk M; Ławicki S
Cancer Manag Res; 2020; 12():10949-10964. PubMed ID: 33154674
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.
Tsuboi M; Kondo K; Masuda K; Tange S; Kajiura K; Kohmoto T; Takizawa H; Imoto I; Tangoku A
Cancer Med; 2019 Aug; 8(9):4189-4199. PubMed ID: 31207151
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Miao S; Zhou SY; Han CS; Zhang LN; Sun HB; Yang B
Drug Des Devel Ther; 2015; 9():3729-40. PubMed ID: 26229436
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.
Hirashita T; Iwashita Y; Ohta M; Komori Y; Eguchi H; Yada K; Kitano S
J Gastrointest Surg; 2012 Apr; 16(4):842-8. PubMed ID: 22246855
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the MMP-7 gene and breast cancer survival.
Beeghly-Fadiel A; Shu XO; Long J; Li C; Cai Q; Cai H; Gao YT; Zheng W
Int J Cancer; 2009 Jan; 124(1):208-14. PubMed ID: 18798254
[TBL] [Abstract][Full Text] [Related]
7. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.
Martin MD; Carter KJ; Jean-Philippe SR; Chang M; Mobashery S; Thiolloy S; Lynch CC; Matrisian LM; Fingleton B
Cancer Res; 2008 Aug; 68(15):6251-9. PubMed ID: 18676849
[TBL] [Abstract][Full Text] [Related]
8. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Voorzanger-Rousselot N; Juillet F; Mareau E; Zimmermann J; Kalebic T; Garnero P
Br J Cancer; 2006 Aug; 95(4):506-14. PubMed ID: 16880790
[TBL] [Abstract][Full Text] [Related]
9. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Pelosi G; Scarpa A; Veronesi G; Spaggiari L; Del Curto B; Moore PS; Maisonneuve P; Sonzogni A; Masullo M; Viale G
Virchows Arch; 2005 Dec; 447(6):969-77. PubMed ID: 16158183
[TBL] [Abstract][Full Text] [Related]
10. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
11. Dystroglycan complex in cancer.
Brennan PA; Jing J; Ethunandan M; Górecki D
Eur J Surg Oncol; 2004 Aug; 30(6):589-92. PubMed ID: 15256230
[TBL] [Abstract][Full Text] [Related]
12. The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
Mylona E; Kapranou A; Mavrommatis J; Markaki S; Keramopoulos A; Nakopoulou L
APMIS; 2005 Apr; 113(4):246-55. PubMed ID: 15865605
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
15. Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Mylona EE; Alexandrou PT; Giannopoulou IA; Rafailidis PI; Markaki S; Keramopoulos A; Nakopoulou LL
Cancer Detect Prev; 2006; 30(2):111-7. PubMed ID: 16632244
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
